CanFite Expands Licensing Agreement to Include Pancreatic Cancer Indication
On January 30, 2024, Can-Fite BioPharma Ltd. announced the expansion of its out-licensing agreement with Ewopharma AG, encompassing the inclusion ...
Tag: CANF
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
